RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Revenue

RaQualia Pharma had revenue of 653.01M JPY in the quarter ending June 30, 2026, with 14.64% growth. This brings the company's total for the last twelve months to 3.90B, up 20.67% year-over-year. In the year 2025, RaQualia Pharma had annual revenue of 3.98B with 28.07% growth. That makes RaQualia Pharma the 32,544th largest company in the world by revenue and 3,398th in Japan.

• Revenue (ttm): 3.90B
• Revenue Growth: +20.67%
• P/S Ratio: 4.04
• Revenue / Employee: 45.87M
• Employees: 85
• Market Cap: 15.75B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Asia 2.05B 51.5%
• Japan 1.07B 26.8%
• United States of America 861.00M 21.6%

Fiscal year ended Dec 31, 2025 See the full RaQualia Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.98B	872.00M	28.07%
Dec 31, 2024	3.11B	1.21B	63.44%
Dec 31, 2023	1.90B	-1.02B	-34.85%
Dec 31, 2022	2.92B	142.00M	5.12%
Dec 31, 2021	2.78B	1.67B	150.77%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error